5-Methoxy-N,N-diisopropyltryptamine

DB01441ExperimentalIllicitSmall molecule

5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) is a tryptamine derivative and shares many similarities with schedule I tryptamine hallucinogens such as alpha-ethyltryptamine, N,N-dimethyltryptamine, N,N-diethyltryptamine, bufotenine, psilocybin and psilocin. Since 1999, there has been a... This substance is abused for its hallucinogenic effects.

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2C, and Sodium-dependent serotonin transporter
Curator reviewed
Formula / weight: C₁₇H₂₆N₂O · 274.4011 g/mol (avg)
Also known as: 5-MeO-DIPT · Foxy · Foxy methoxy

Resolves to

Compound

UNII12D06G8W8ECAS4021-34-5ChEMBLCHEMBL2140942ChEBI48282PubChem151182

Structure

InChIKeyDNBPMBJFRRVTSJ-UHFFFAOYSA-NSMILESCOC1=CC2=C(NC=C2CCN(C(C)C)C(C)C)C=C1

Targets

P28223HTR2AP28335HTR2CP31645SLC6A4

What you can answer from here — as of September 19, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

12+ReferencesStructured and connected to the statements they support

Which drugs share a target with 5-Methoxy-N,N-diisopropyltryptamine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account